Related Experiment Video
Updated: Jun 4, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
The genetic epidemiology of melanocortin 4 receptor variants
1Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, P.O. Box 285, Cambridge, CB5 8QD, United Kingdom. ruth.loos@mrc-epid.cam.ac.uk
Abstract:
While rare MC4R mutations are the commonest cause of monogenic forms of extreme, early-onset obesity, growing evidence shows that common MC4R variants contribute to obesity in the general population. Candidate gene studies have focussed on the V103I and I251L MC4R variants that both affect MC(4) receptor function in vitro. Individual association studies, which are typically small and underpowered, have found no association between V103I (frequency of 103I-allele: ~4%) or I251L (251L-allele: ~2%) and the risk of obesity in the general population. However, large-scale meta-analyses have confirmed that both variants reduce the risk of obesity by -21% in 103I-allele carriers (P<10(-4)) and by -50% in 251L-allele carriers (P<10(-4)). Recently, genome-wide association studies have identified a common variant (minor allele frequency: ~27%) at ~188kb downstream of MC4R showing robust association (P<5×10(-8)) with BMI and obesity in adults and children. Each additional minor allele increases BMI by 0.20kg/m(2), body weight by 700-1000g, and obesity risk by 14% in adults. Interestingly, this variant also showed association with increased height, consistent with the phenotype seen for rare MC4R mutations. Although MC4R is the nearest gene and phenotypic associations are consistent with those of MC4R mutations, it has not yet been established whether this variant indeed reflects MC(4) receptor function. Taken together, common MC4R variants contribute to variation in BMI and obesity risk in the general population. Of particular interest is the finding from genome-wide association studies that suggests that the region downstream of MC4R contributes to its regulation.
Insights
Common variants in the melanocortin 4 receptor (MC4R) gene influence body weight and obesity risk in the general population. Large studies confirm MC4R variants significantly reduce obesity risk, impacting BMI and body weight.
Area of Science:
- Genetics and Genomics
- Metabolic Disorders
- Obesity Research
Background:
- Rare mutations in the melanocortin 4 receptor (MC4R) gene are a primary cause of monogenic obesity.
- Increasing evidence suggests common MC4R variants also contribute to obesity susceptibility in the general population.
- Previous studies on specific MC4R variants (V103I, I251L) yielded inconclusive results due to small sample sizes.
Purpose of the Study:
- To investigate the contribution of common MC4R variants to obesity risk in the general population.
- To analyze the association of MC4R variants with Body Mass Index (BMI) and obesity.
- To explore the potential regulatory role of genetic variants near the MC4R gene.
Main Methods:
- Meta-analyses of candidate gene studies for MC4R variants V103I and I251L.
- Genome-wide association studies (GWAS) to identify common variants associated with BMI and obesity.
- Analysis of variant frequencies, effect sizes on BMI, body weight, and obesity risk.
Main Results:
- Large-scale meta-analyses confirmed that MC4R variants V103I and I251L significantly reduce obesity risk (by -21% and -50%, respectively).
- GWAS identified a common variant downstream of MC4R strongly associated with BMI and obesity risk in adults and children.
- This common variant increases BMI, body weight, and obesity risk, and is also associated with increased height.
Conclusions:
- Common MC4R variants play a significant role in determining BMI and obesity risk across the general population.
- Genetic variants near the MC4R gene, potentially influencing its regulation, contribute to obesity.
- These findings highlight the importance of MC4R in both rare and common forms of obesity.
More Related Videos
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Incomplete Dominance
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

